These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Olivotto I; Girolami F; Ackerman MJ; Nistri S; Bos JM; Zachara E; Ommen SR; Theis JL; Vaubel RA; Re F; Armentano C; Poggesi C; Torricelli F; Cecchi F Mayo Clin Proc; 2008 Jun; 83(6):630-8. PubMed ID: 18533079 [TBL] [Abstract][Full Text] [Related]
10. Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy. Wang H; Li Z; Wang J; Sun K; Cui Q; Song L; Zou Y; Wang X; Liu X; Hui R; Fan Y Am J Hum Genet; 2010 Nov; 87(5):687-93. PubMed ID: 20970104 [TBL] [Abstract][Full Text] [Related]
11. Deep basal inferoseptal crypts occur more commonly in patients with hypertrophic cardiomyopathy due to disease-causing myofilament mutations. Deva DP; Williams LK; Care M; Siminovitch KA; Moshonov H; Wintersperger BJ; Rakowski H; Crean AM Radiology; 2013 Oct; 269(1):68-76. PubMed ID: 23771913 [TBL] [Abstract][Full Text] [Related]
12. Gene mutations in apical hypertrophic cardiomyopathy. Arad M; Penas-Lado M; Monserrat L; Maron BJ; Sherrid M; Ho CY; Barr S; Karim A; Olson TM; Kamisago M; Seidman JG; Seidman CE Circulation; 2005 Nov; 112(18):2805-11. PubMed ID: 16267253 [TBL] [Abstract][Full Text] [Related]
13. [Biventriculographic and clinicopathologic evaluation of apical hypertrophy: with reference to asymmetrical septal hypertrophy with hypertension]. Genda A; Taga K; Nakayama A; Nunoda S; Horita Y; Sugihara N; Takeda R J Cardiogr; 1985 Jun; 15(2):327-38. PubMed ID: 4093618 [TBL] [Abstract][Full Text] [Related]
14. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Gruner C; Care M; Siminovitch K; Moravsky G; Wigle ED; Woo A; Rakowski H Circ Cardiovasc Genet; 2011 Jun; 4(3):288-95. PubMed ID: 21511876 [TBL] [Abstract][Full Text] [Related]
15. Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathy. Cecconi M; Parodi MI; Formisano F; Spirito P; Autore C; Musumeci MB; Favale S; Forleo C; Rapezzi C; Biagini E; Davì S; Canepa E; Pennese L; Castagnetta M; Degiorgio D; Coviello DA Int J Mol Med; 2016 Oct; 38(4):1111-24. PubMed ID: 27600940 [TBL] [Abstract][Full Text] [Related]
16. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. McLeod CJ; Bos JM; Theis JL; Edwards WD; Gersh BJ; Ommen SR; Ackerman MJ Am Heart J; 2009 Nov; 158(5):799-805. PubMed ID: 19853701 [TBL] [Abstract][Full Text] [Related]
17. Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy. Sherrrid MV; Mahenthiran J; Casteneda V; Fincke R; Gasser M; Barac I; Thayaparan R; Chaudhry FA Am J Cardiol; 2006 Jan; 97(1):106-12. PubMed ID: 16377293 [TBL] [Abstract][Full Text] [Related]
18. [Mode of hypertrophy in hypertrophic cardiomyopathy based on the external shape of the left ventricle: a two-dimensional echocardiographic study]. Hashimoto M; Mikami T; Kudo T; Sugawara T; Yasuda H J Cardiol; 1990; 20(4):871-8. PubMed ID: 2133722 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028 [TBL] [Abstract][Full Text] [Related]
20. Cardiac muscle cell disorganization in apical hypertrophic cardiomyopathy: a cardiac biopsy study. Morimoto S; Sekiguchi M; Uemura A; Hiramitsu S; Kimura K; Ohtsuki M; Ishii J; Kato S; Kasanuki H; Hishida H Jpn Heart J; 2003 Jul; 44(4):505-13. PubMed ID: 12906032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]